Research & education Industry development
Isomorphic Labs announces $5 billion Series C funding
Isomorphic Labs announced $5 billion in Series C funding to expand its AI drug-design engine, therapeutic-candidate programs and bioengineering infrastructure. [1][2]
What happened
The official announcement identifies Greenoaks and Sequoia Capital as co-leads. Its accompanying release describes development of IsoDDE and work toward clinical trials. [1][2]
Why it matters
The financing supports AI-led drug discovery and the infrastructure needed to investigate whether computationally designed candidates can become medicines. [1][2]
Key dates
Risks and open questions
Reported preclinical progress is a company statement. The announcement does not establish clinical efficacy, a completed trial, regulatory approval or an available medicine. [1][2]
Sources and verification
Catalog evidence checked How we verify records
- Primary source Isomorphic Labs announces Series C investment round
- Primary source Isomorphic Labs November 17 funding release
Related profiles
Research & education
NVIDIA Nemotron for Science
NVIDIA
The collection packages technical components for researchers and scientific computing teams.
Research & education
GraphCast
Google DeepMind
Uses recent atmospheric states to predict future weather variables including wind, temperature and air pressure.
Research & education
Khanmigo
Khan Academy
It provides guided practice and supports teaching tasks through an education-focused chat interface.